Christoph Nerl

Autologous Stem-Cell Transplantation As First-Line Therapy in Peripheral T-Cell Lymphomas: Results of a Prospective Multicenter Study

Peter Reimer, Thomas Rüdiger, Eva Geissinger et al. · Journal of Clinical Oncology · 2008 · 422 citations

Medicine, Oncology, Cell Therapy +14

Positron emission tomography in non-Hodgkin's lymphoma: assessment of chemotherapy with fluorodeoxyglucose.

Wolfgang Römer, Axel-R. Hanauske, Sibylle Ziegler et al. · PubMed · 1998 · 338 citations

Medicine, Oncology, Radiology +10

Tolerability-Adapted Imatinib 800 mg/d Versus 400 mg/d Versus 400 mg/d Plus Interferon-α in Newly Diagnosed Chronic Myeloid Leukemia

Rüdiger Hehlmann, Michael Lauseker, Susanne Jung-Munkwitz et al. · Journal of Clinical Oncology · 2011 · 323 citations · Full text

Pharmacy, Hematology, Pharmacotherapy +12

Deep Molecular Response Is Reached by the Majority of Patients Treated With Imatinib, Predicts Survival, and Is Achieved More Quickly by Optimized High-Dose Imatinib: Results From the Randomized CML-Study IV

Rüdiger Hehlmann, Martin C. Müller, Michael Lauseker et al. · Journal of Clinical Oncology · 2013 · 299 citations · Full text

Medicine, Hematology, Pharmacology +13

Intracellular and Surface Expression of the HIV-1 Coreceptor CXCR4/Fusin on Various Leukocyte Subsets: Rapid Internalization and Recycling Upon Activation

Reinhold Förster, Elisabeth Kremmer, Andreas Schubel et al. · The Journal of Immunology · 1998 · 257 citations · Full text

Life Sciences, Cell Biology, Immunology +15